Xellia and Kabi Broaden US Antibiotics Offering

New Offerings Of Vancomycin And Ertapenem

 
• By Aidan Fry
  
Syringes
Xellia and Fresenius Kabi have expanded their injectable antibiotics portfolio in the US • Source: Shutterstock

More from Products

More from Generics Bulletin